Crossmark

A novel TLR4 binding protein, 40S ribosomal protein S3, has potential utility as an adjuvant in a dendritic cell-based vaccine

Crossref DOI link: https://doi.org/10.1186/s40425-019-0539-7

Published Online: 2019-02-28

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Park, Hyun Jin

Jang, Gun-Young

Kim, Young Seob

Park, Jung Hwa

Lee, Sung Eun

Vo, Manh-Cuong

Lee, Je-Jung

Han, Hee Dong

Jung, In Duk

Kang, Tae Heung https://orcid.org/0000-0002-9853-913X
Park, Yeong-Min
Funding

Funding for this research was provided by:

National Research Foundation of Korea (2016R1A5A2012284, 2018R1A2B6008455)

Korea Health Industry Development Institute (HI15C2524)
More Information

Article History

Received: 18 October 2018

Accepted: 20 February 2019

First Online: 28 February 2019

Ethics approval and consent to participate

: Not applicable.

: Not applicable.

: The authors declare that they have no competing interests.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.